The Federal Trade Commission settles a complaint against ZyCal Bioceuticals Healthcare Company Inc. about claims that its Ostinol hydrolyzed collagen dietary supplements grow bone and cartilage to relieve joint pain.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?